Literature DB >> 3136965

Arterial thrombotic manifestations in young women associated with the lupus anticoagulant.

E J Ter Borg1, J Van der Meer, J T De Wolf, M H Van Leeuwen, C G Kallenberg.   

Abstract

To demonstrate the wide variety of clinical syndromes associated with the lupus anticoagulant (LAC), we report the case histories of three young females with arterial thrombosis in whom LAC was demonstrated. Two patients had a diagnosis of systemic lupus erythematosus and mixed connective tissue disease respectively; the other patient had no signs of underlying auto-immune disease. Arterial thrombotic events in young females should arouse suspicion of the presence of LAC although its pathophysiological significance is not established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3136965     DOI: 10.1007/bf02284060

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  A clinical study of the lupus anticoagulant.

Authors:  M A Schleider; R L Nachman; E A Jaffe; M Coleman
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

2.  Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant.

Authors:  R Cariou; G Tobelem; C Soria; J Caen
Journal:  N Engl J Med       Date:  1986-05-01       Impact factor: 91.245

3.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

4.  Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis.

Authors:  T M Cosgriff; B A Martin
Journal:  Arthritis Rheum       Date:  1981-01

5.  Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure.

Authors:  D A Triplett; J T Brandt; D Kaczor; J Schaeffer
Journal:  Am J Clin Pathol       Date:  1983-06       Impact factor: 2.493

6.  Intrauterine death and circulating anticoagulant ("antithromboplastin").

Authors:  I M Nilsson; B Astedt; U Hedner; D Berezin
Journal:  Acta Med Scand       Date:  1975-03

7.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

8.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

9.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

10.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

View more
  3 in total

1.  Antiphospholipid antibodies, lupus-like disease and the "primary" antiphospholipid syndrome.

Authors:  R A Asherson; M A Khanashta; G R Hughes
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 3.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.